HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CA-50 antigen

CA-50 ANTIGEN was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94

Also Known As:

CA 50 antigen

Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Biological Factors: 2472
- Biomarkers: 240291
  - Tumor Biomarkers: 15272
    - Carbohydrate Tumor-Associated Antigens: 355
      - CA-50 antigen: 10
- Antigens: 143924
  - Epitopes: 19548
    - Carbohydrate Tumor-Associated Antigens: 355
      - CA-50 antigen: 10
  - Neoplasm Antigens: 6217
    - Carbohydrate Tumor-Associated Antigens: 355
      - CA-50 antigen: 10

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 11/01/1993 - "The present study evaluated the biological behaviour of the CA 50 antigen in malignant superficial, deep localized and disseminated bladder tumors. " 08/01/1991 - "Immunohistochemical staining of CA 50 antigen in human bladder cancer. " 11/01/1993 - "Our results indicate that the carbohydrate CA 50 antigen can be utilized as a prognostic marker in patients with malignant bladder tumors. "
2.	Pancreatic Neoplasms (Pancreatic Cancer) 01/01/1987 - "The serum CA-50 antigen, as determined by the assay employed here, has a high sensitivity (92%) for exocrine pancreatic carcinoma. " 04/15/1987 - "The CA 50 antigen is similar, but not identical, to the tumor marker CA 19-9. The serum concentrations of CA 50 were measured by an immunoradiometric assay (CA 50 IRMA) in 95 patients with pancreatic cancer and in 94 patients with benign pancreatic, biliary and hepatocellular diseases. " 12/01/1988 - "Plasma concentrations of CA-50 antigen in samples from patients suffering from pancreatic cancer, chronic pancreatitis and abdominal pain of unknown origin were analysed by three different techniques, using the same monoclonal antibody, C-50 Mab. These methods include an inhibition assay, an immunoradiometric assay (IRMA), and a dissociation-enhanced lanthanide fluoro-immunoassay (DELFIA). "
3.	Neoplasms (Cancer) 12/01/1990 - "The CA-50 antigen is known to be elevated in different types of gynecological neoplasia. " 11/01/1987 - "Serum CA-50 antigen in the normal individuals and cancer patients was assayed by radioimmunoassay. " 11/01/1987 - "Using the latest CA-50 antigen radioimmunoinhibition test kits prepared by Steana Diagnostics AB Company, Sweden, the serum CA-50 content was measured in 62 normal individuals, 9 primary hepatocellular carcinomas, 9 liver benign tumors, 23 ovarian or uterine carcinomas, 22 other malignancies and 21 benign tumors. " 05/01/1989 - "CA 50 antigen expression was still detected in tumor cells lacking the CA 19-9 antigen and C 50 reactive material was found in all tissue specimens from medullary carcinomas tested, whereas CA 19-9 antigen staining was consistently negative. "
4.	Chronic Pancreatitis 12/01/1988 - "Plasma concentrations of CA-50 antigen in samples from patients suffering from pancreatic cancer, chronic pancreatitis and abdominal pain of unknown origin were analysed by three different techniques, using the same monoclonal antibody, C-50 Mab. These methods include an inhibition assay, an immunoradiometric assay (IRMA), and a dissociation-enhanced lanthanide fluoro-immunoassay (DELFIA). "
5.	Medullary Carcinoma 05/01/1989 - "CA 50 antigen expression was still detected in tumor cells lacking the CA 19-9 antigen and C 50 reactive material was found in all tissue specimens from medullary carcinomas tested, whereas CA 19-9 antigen staining was consistently negative. "

Related Drugs and Biologics

1.	Lanthanoid Series Elements (Lanthanides)
2.	CA-19-9 Antigen (CA 19-9 Antigen)
3.	Tumor Biomarkers (Tumor Markers)
4.	Phosphopyruvate Hydratase (Enolase)
5.	Carcinoembryonic Antigen
6.	Carbohydrates
7.	Monoclonal Antibodies